Law Firm Probes GBTG's Proposed Sale Price
NEW YORK, May 23 —
A securities law firm has launched an investigation into whether Global Business Travel Group shareholders are receiving adequate price and process in the company's proposed sale. The filing record shows five supplemental proxy disclosures in seven weeks, the company's chief technology officer selling more than a million dollars in stock, and independent analysis from Morningstar questioning the deal price.
- CTO John David Thompson sold 108,908 shares at $9.34 on May 4, collecting $1,017,200.72 — his second large open-market sale in two months
- GBTG filed five DEFA14A supplemental proxy disclosures between April 2 and May 21, 2026
- Eight insiders each received grants of 23,429 shares on May 13, days after the CTO's sale
Two Doubters, One Deal
Kahn Swick & Foti, LLC's investigation covers two questions: whether the board ran a legitimate sale process and whether the resulting price reflects full value. Morningstar reached the same concern independently, publishing analysis questioning whether GBTG shareholders are getting a fair deal. Two separate parties raising the same objection puts pressure on management to justify the transaction before the shareholder vote is certified.
The CTO's Exit, in Two Installments
John David Thompson sold 109,020 shares at $5.74 on March 4, collecting $625,774.80. Two months later, on May 4, the same day GBTG filed an earnings 8-K reporting quarterly results, he sold another 108,908 shares at $9.34, for $1,017,200.72. The sale price rose from $5.74 to $9.34 between transactions. Combined, Thompson sold roughly $1.64 million in stock while the deal's proxy campaign was running. Open-market insider sales during a pending acquisition don't automatically signal anything. But the CTO clearing a substantial stake in two tranches at rising prices raises a direct question. If the deal price is fair to shareholders, why is the executive with the deepest knowledge of the company's operations selling at market rather than waiting for the close?
A Proxy Campaign Under Pressure
GBTG filed its definitive proxy on April 2, then followed with five DEFA14A supplemental disclosures: on April 2, May 4, May 4, May 5, and May 21. Companies file supplemental proxy disclosures to address shareholder questions, counter objections, or update the terms of their pitch. Five filings in seven weeks is an active solicitation campaign, not a routine approval process. On May 18, a separate 8-K confirmed matters were submitted to a security holder vote.
Grants While the CTO Sold
On May 13, nine days after Thompson's second sale, eight individuals each received grants of 23,429 shares: Michael Gregory Ohara, Raymond Joabar, Susan F. Ward, James Peter Bush, Kathleen A. Winters, Al-thani Faisal Saoud F.q., Ugo Arzani, and Alexander Drummond. The grants came two days after a May 12 8-K reporting a director or officer departure or appointment. Pre-close equity awards are standard retention tools in M&A. But the timing is specific: the CTO sold at market prices while eight colleagues received new shares in the same two-week window.
What the Vote Will Show
The shareholder vote is the next disclosure checkpoint. Its outcome will show whether the proxy campaign succeeded despite the Kahn Swick investigation and Morningstar's fair-value objections. Whether the law firm's inquiry advances to litigation or triggers a price renegotiation is a separate question the vote won't settle. Five supplemental proxy filings, two rounds of CTO selling, and two independent parties questioning the deal price are now on the record. Institutional holders will indicate how they weigh that evidence.
Run the free Global Business Travel Group, Inc. deep-dive →
Basis Report does not hold positions in securities discussed. This is not investment advice.
Frequently Asked Questions
Is GBTG's proposed sale under investigation?
Yes. Kahn Swick & Foti, LLC announced an investigation into the adequacy of price and process in GBTG's proposed sale. Morningstar separately published analysis questioning whether shareholders are getting a fair deal. Two parties are raising the same concern independently.
Did GBTG's CTO sell shares before the deal closed?
CTO John David Thompson made two open-market sales: 109,020 shares at $5.74 on March 4, 2026, for $625,774.80, and 108,908 shares at $9.34 on May 4, 2026, for $1,017,200.72. The May 4 sale happened on the same day GBTG filed an earnings 8-K reporting quarterly results.
What are GBTG's DEFA14A proxy filings about?
DEFA14A filings are supplemental proxy disclosures that companies use to provide shareholders with additional information during a vote. GBTG filed five of them between April 2 and May 21, 2026. That frequency signals an active campaign to address shareholder questions or counter objections to the sale.
Have GBTG shareholders voted on the proposed acquisition?
GBTG filed an 8-K on May 18, 2026, confirming that matters were submitted to a vote of security holders. The company had filed its definitive proxy statement on April 2, 2026, setting the formal process in motion. The final disclosed vote outcome was not available in filings reviewed for this article.
Who received GBTG share grants in May 2026?
Eight individuals each received grants of 23,429 shares on May 13, 2026, including Michael Gregory Ohara, Raymond Joabar, Susan F. Ward, James Peter Bush, Kathleen A. Winters, Al-thani Faisal Saoud F.q., Ugo Arzani, and Alexander Drummond. The grants came two days after GBTG filed an 8-K on May 12 reporting a director or officer departure or appointment.